OA11040A - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations Download PDF

Info

Publication number
OA11040A
OA11040A OA9900091A OA9900091A OA11040A OA 11040 A OA11040 A OA 11040A OA 9900091 A OA9900091 A OA 9900091A OA 9900091 A OA9900091 A OA 9900091A OA 11040 A OA11040 A OA 11040A
Authority
OA
OAPI
Prior art keywords
préparation
free base
binder
tablet
siidénafil
Prior art date
Application number
OA9900091A
Other languages
English (en)
Inventor
Cristi Bell-Huff
Thomas Francis Dolan
Angela Carol Gatlin Hausberger
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA11040A publication Critical patent/OA11040A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicon Polymers (AREA)
OA9900091A 1998-05-15 1999-04-30 Pharmaceutical formulations OA11040A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8564698P 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
OA11040A true OA11040A (en) 2003-01-01

Family

ID=22193027

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900091A OA11040A (en) 1998-05-15 1999-04-30 Pharmaceutical formulations

Country Status (32)

Country Link
US (1) US20020002172A1 (is)
EP (1) EP0960621A3 (is)
JP (1) JPH11349483A (is)
KR (1) KR19990088249A (is)
CN (1) CN1251758A (is)
AP (1) AP9901534A0 (is)
AR (1) AR016481A1 (is)
AU (1) AU753478B2 (is)
BG (1) BG103396A (is)
BR (1) BR9902086A (is)
CA (1) CA2272042A1 (is)
CO (1) CO5060503A1 (is)
DZ (1) DZ2786A1 (is)
EA (1) EA002830B1 (is)
GT (1) GT199900061A (is)
HN (1) HN1999000066A (is)
HR (1) HRP990144A2 (is)
HU (1) HUP9901606A2 (is)
ID (1) ID23299A (is)
IS (1) IS5046A (is)
MA (1) MA26629A1 (is)
NO (1) NO992339L (is)
NZ (1) NZ335772A (is)
OA (1) OA11040A (is)
PA (1) PA8472901A1 (is)
PE (1) PE20000546A1 (is)
PL (1) PL333118A1 (is)
SG (1) SG79255A1 (is)
SK (1) SK61599A3 (is)
TR (1) TR199901077A3 (is)
YU (1) YU21999A (is)
ZA (1) ZA993338B (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020033A1 (en) * 1998-10-05 2000-04-13 Eisai Co., Ltd. Tablets immediately disintegrating in the oral cavity
AU3724400A (en) * 1999-03-08 2000-09-28 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
EP1171134A4 (en) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
CN1264574C (zh) * 2000-09-06 2006-07-19 田边制药株式会社 口服制剂
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (is) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
JPWO2003028706A1 (ja) * 2001-09-28 2005-01-13 株式会社三和化学研究所 有核型速溶崩壊性成型品
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
CA2612917A1 (en) * 2005-06-23 2007-01-04 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
US8337817B2 (en) * 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
CN101674728A (zh) * 2007-02-12 2010-03-17 Dmi生物科学公司 降低曲马多的副作用
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
FR2932682B1 (fr) * 2008-06-23 2013-07-12 Bionetwork Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
US8617588B2 (en) 2009-03-09 2013-12-31 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
EP2338474A1 (de) * 2009-12-23 2011-06-29 Ratiopharm GmbH Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
BR112013020237A2 (pt) * 2011-02-11 2021-03-16 Ctc Bio, Inc. Processo para preparar um filme contendo base livre de sildenafila e filme contendo base livre de sildenafila
KR101418406B1 (ko) * 2011-08-24 2014-07-10 한미약품 주식회사 실데나필 유리 염기를 포함하는 구강 붕해정
MX366768B (es) * 2011-12-08 2019-07-17 Laboratorios Liomont S A De C V Tableta orodispersable de sildenafil y metodo para preparar la misma.
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN114246835A (zh) * 2022-01-05 2022-03-29 河北龙海药业有限公司 一种枸橼酸西地那非口腔崩解片的制备方法
WO2025048919A1 (en) * 2023-08-30 2025-03-06 Dow Global Technologies Llc Spray dried excipient blends

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE19532142A1 (de) * 1995-08-31 1997-03-06 Siemens Ag Verfahren und Vorrichtung zur Regelung eines vierdimensionalen Vektors einer Strecke mittels eines wertediskreten Stellgliedes mit begrenzter Schaltfrequenz
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
WO1998053819A1 (en) * 1997-05-29 1998-12-03 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for erection failure
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
EP1171134A4 (en) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL

Also Published As

Publication number Publication date
HU9901606D0 (en) 1999-07-28
BR9902086A (pt) 2000-05-02
DZ2786A1 (fr) 2003-12-01
AP9901534A0 (en) 1999-06-30
US20020002172A1 (en) 2002-01-03
EP0960621A2 (en) 1999-12-01
CN1251758A (zh) 2000-05-03
HN1999000066A (es) 1999-09-29
CO5060503A1 (es) 2001-07-30
NO992339L (no) 1999-11-16
AR016481A1 (es) 2001-07-04
BG103396A (bg) 2000-01-31
PL333118A1 (en) 1999-11-22
SK61599A3 (en) 2000-12-11
YU21999A (sh) 2002-03-18
IS5046A (is) 1999-11-16
HRP990144A2 (en) 2000-02-29
SG79255A1 (en) 2001-03-20
EP0960621A3 (en) 2000-01-05
AU753478B2 (en) 2002-10-17
CA2272042A1 (en) 1999-11-15
TR199901077A2 (en) 1999-12-21
TR199901077A3 (tr) 1999-12-21
JPH11349483A (ja) 1999-12-21
PE20000546A1 (es) 2000-07-07
ZA993338B (en) 2000-11-14
PA8472901A1 (es) 2000-09-29
GT199900061A (es) 2000-10-14
ID23299A (id) 2000-04-05
NZ335772A (en) 2000-12-22
HUP9901606A2 (en) 2002-09-28
NO992339D0 (no) 1999-05-14
KR19990088249A (ko) 1999-12-27
EA199900373A2 (ru) 1999-12-29
MA26629A1 (fr) 2004-12-20
EA199900373A3 (ru) 2000-08-28
AU2812699A (en) 1999-11-25
EA002830B1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
OA11040A (en) Pharmaceutical formulations
TWI288002B (en) Orally disintegrating tablets and process for obtaining them
RU2436565C2 (ru) Распадающиеся пероральные пленки
US6455053B1 (en) Quickly soluble solid preparations
EP0542824B1 (fr) Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee
US6187336B1 (en) Process for producing a solid which is rapidly soluble in the oral cavity
EP1246668B1 (en) An rapid acting freeze dired oral pharmaceutical composition for treating migraine
US20020001617A1 (en) Rapidly disintegrating tablet and process for the manufacture thereof
JP4074675B2 (ja) トラマドール又はトラマドール塩の急速に崩壊する薬剤形
CA2440361A1 (en) Intraorally rapidly disintegrable preparation
EP1121103A2 (en) Orally disintegrable tablets
JP5209492B2 (ja) 速崩性錠剤製造のための医薬製剤
JP2003531161A (ja) 発泡性顆粒剤およびその調製法
KR20090043528A (ko) 알리스키렌의 갈레닉 제제
WO2004096214A1 (en) A rapidly disintegrable composition for masking the bitter taste of ondansetron or a pharmaceutically acceptable salt thereof
CN100544709C (zh) 抗血栓形成的化合物的可在口中分散的药物组合物
KR102752715B1 (ko) 두타스테리드 및 타다라필을 포함하는 복합제제 및 이의 제조방법
JPH11116464A (ja) 迅速溶解性固形製剤およびその製造法
HK1026634A (en) Pharmaceutical formulations
CZ159199A3 (cs) Farmaceutický přípravek rozpadající se v ústech a způsob léčení sexuální dysfunkce
CN121197111A (zh) 依达拉奉口腔溶膜速释制剂组合物及其制剂和用途
HK1094152B (en) Orodispersible pharmaceutical composition of an antithrombotic compound
HK1059571A (en) Preparations quickly disintegrating in oral cavity
HK1076743A1 (en) Orodispersible pharmaceutical composition comprising perindopril
HK1027504A (en) Quickly soluble solid preparations